MME and neoplasm: Given the existence of rare EPN subtypes e.g., PF-EPN with ZFTA rearrangement [65] or ST-EPN harboring ZFTA fusions with atypical (non-RELA) partners, correct identification of a tumor with a particular group requires an extended diagnostic algorithm accounting for gene expression signatures.